The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $68.50

Today's change+1.57 +2.35%
Updated April 27 2:51 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $68.50

Today's change+1.57 +2.35%
Updated April 27 2:51 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc Hits New 20-day High

Seattle Genetics Inc is up sharply today, rallying (U.S.)$1.57 or 2.35% to (U.S.)$68.50 and setting a new 20-day high. Over the last five days, shares have gained 2.18% and 29.81% year to date. Shares have outperformed the S&P 500 by 65.86% during the last year.

Key company metrics

  • Open(U.S.) $67.25
  • Previous close(U.S.) $66.93
  • High(U.S.) $68.72
  • Low(U.S.) $66.61
  • Bid / Ask(U.S.) $68.46 / (U.S.) $68.55
  • YTD % change+29.81%
  • Volume253,383
  • Average volume (10-day)558,217
  • Average volume (1-month)645,109
  • Average volume (3-month)930,340
  • 52-week range(U.S.) $32.40 to (U.S.) $75.36
  • Beta2.31
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.99
Updated April 27 2:51 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue10510695111
Total other revenue--------
Total revenue10510695111
Gross profit949585102
Total cost of revenue12111010
Total operating expense161139129132
Selling / general / administrative41353330
Research & development108938693
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-56-32-33-21
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-55-32-33-20
Income after tax-55-32-33-20
Income tax, total--------
Net income-55-32-33-20
Total adjustments to net income--------
Net income before extra. items-55-32-33-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-55-32-33-20
Inc. avail. to common incl. extra. items-55-32-33-20
Diluted net income-55-32-33-20
Dilution adjustment--------
Diluted weighted average shares142141140140
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.23-0.23-0.15
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.39-0.23-0.23-0.15